MarketCap
Facebook
X
TelegramCRH Medical Corporation Revenue 2011-2026 | CRHM
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue CRH Medical Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 106 M | 120 M | 113 M | 100 M | 78.4 M | 46 M | 12 M | 7.68 M | 6.85 M | 5.53 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 120 M | 5.53 M | 59.6 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical instruments industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
169 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
2.75 B | $ 20.66 | 1.27 % | $ 10.5 B | USA |
 |
Becton, Dickinson and Company
BDX
|
21.8 B | $ 205.09 | 1.16 % | $ 59 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
17.9 M | $ 8.15 | -7.6 % | $ 164 M | USA |
 |
Luminex Corporation
LMNX
|
417 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.58 M | - | -9.52 % | $ 20.6 M | USA |
 |
Harvard Bioscience
HBIO
|
112 M | $ 0.66 | -1.92 % | $ 28 M | USA |
 |
iRhythm Technologies
IRTC
|
592 M | $ 188.16 | 0.41 % | $ 5.87 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
150 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.02 B | - | -1.18 % | $ 3.4 B | USA |
 |
Masimo Corporation
MASI
|
2.09 B | $ 138.18 | 0.8 % | $ 7.36 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.88 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
3.17 B | - | -0.02 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
1.36 B | $ 84.98 | 2.36 % | $ 4.28 B | USA |
 |
OraSure Technologies
OSUR
|
186 M | $ 2.65 | 5.38 % | $ 197 M | USA |
 |
Alcon
ALC
|
9.91 B | $ 80.67 | -0.38 % | $ 40.4 B |  Schweiz |
 |
Predictive Oncology
POAI
|
1.62 M | $ 6.85 | 3.24 % | $ 37.4 M | USA |
 |
AtriCure
ATRC
|
465 M | $ 42.59 | 1.96 % | $ 2 B | USA |
 |
electroCore
ECOR
|
16 M | $ 5.15 | 6.19 % | $ 28.4 K | USA |
 |
ICU Medical
ICUI
|
2.38 B | $ 152.88 | 1.7 % | $ 3.73 B | USA |
 |
AngioDynamics
ANGO
|
292 M | $ 10.02 | -8.29 % | $ 409 M | USA |
 |
The Cooper Companies
COO
|
4.09 B | $ 83.38 | -0.63 % | $ 16.6 B | USA |
 |
Isoray
ISR
|
3.55 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
5.46 B | $ 260.64 | 0.52 % | $ 25.7 B | USA |
 |
Glaukos Corporation
GKOS
|
315 M | $ 114.49 | 0.43 % | $ 5.55 B | USA |
 |
InfuSystem Holdings
INFU
|
110 M | $ 8.9 | -0.11 % | $ 184 M | USA |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 5.79 | 3.02 % | $ 264 M | USA |
 |
LeMaitre Vascular
LMAT
|
220 M | $ 85.05 | 1.55 % | $ 1.91 B | USA |
 |
Intuitive Surgical
ISRG
|
8.35 B | $ 586.15 | -1.03 % | $ 208 B | USA |
 |
Merit Medical Systems
MMSI
|
1.36 B | $ 93.33 | 1.83 % | $ 5.43 B | USA |
 |
Utah Medical Products
UTMD
|
12.3 M | $ 58.5 | 1.39 % | $ 212 M | USA |
 |
Nephros
NEPH
|
14.2 M | $ 5.07 | -1.74 % | $ 52.7 M | USA |
 |
Microbot Medical
MBOT
|
117 K | $ 2.19 | 3.55 % | $ 22.3 M |  Israel |
 |
Milestone Scientific
MLSS
|
8.63 M | $ 0.29 | 2.24 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
3.03 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.51 B | $ 23.52 | 2.53 % | $ 4.05 B | USA |
 |
Pro-Dex
PDEX
|
66.6 M | $ 41.83 | 4.47 % | $ 138 M | USA |
 |
Pulse Biosciences
PLSE
|
700 K | $ 14.71 | -3.26 % | $ 707 M | USA |
 |
Repligen Corporation
RGEN
|
632 M | $ 165.12 | -2.32 % | $ 9.2 M | USA |
 |
ResMed
RMD
|
3.58 B | $ 250.85 | 1.07 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
82.3 M | $ 24.91 | -1.97 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
26.8 M | $ 2.57 | -1.35 % | $ 207 M | USA |
 |
Retractable Technologies
RVP
|
33 M | $ 0.76 | -0.53 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
314 M | $ 22.43 | 1.08 % | $ 1.1 B | USA |
 |
Teleflex Incorporated
TFX
|
3.05 B | $ 110.0 | -13.07 % | $ 5.15 B | USA |
 |
West Pharmaceutical Services
WST
|
2.89 B | $ 274.0 | -1.62 % | $ 20 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
3.79 B | $ 12.53 | 1.25 % | $ 2.55 B | USA |